Details for Patent: 6,653,286

✉ Email this page to a colleague

Summary for Patent: 6,653,286

Title:	Gonadotropin releasing hormone antagonist
Abstract:	The present invention relates to a method to prevent a premature LH surge. The method employs the administration of the gonadotropin releasing hormone antagonist ganirelix in an amount between 0.125-1 mg in combination with exogenous FSH. The method can be used in the treatment of women undergoing controlled ovarian superovulation.
Inventor(s):	Mannaerts; Bernadette Maria Julia Louise (Acacialaan, NL), Coelingh Bennink; Herman Jan Tijmen (Melvill van Carnebeelaan, NL), Orlemans; Everardus Otto Maria (Wolvespoor, NL)
Assignee:	Akzo Nobel NV (Arnhem, NL)
Application Number:	09/446,324
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 6,653,286

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,653,286

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	97201885	Jun 20, 1997

PCT Information
PCT Filed	June 16, 1998	PCT Application Number:	PCT/EP98/03713
PCT Publication Date:	December 30, 1998	PCT Publication Number:	WO98/58657

International Family Members for US Patent 6,653,286

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	302018	⤷ Sign Up
Australia	8727798	⤷ Sign Up
Germany	69831241	⤷ Sign Up
Denmark	0994718	⤷ Sign Up
European Patent Office	0994718	⤷ Sign Up
Spain	2247710	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.